January 17, 2013

More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

January 17, 2013

Fortune magazine has released its list of the 100 best companies to work for this year, and a number of retailers and suppliers made the cut.

January 16, 2013

An advocacy group focused on a rare lung disorder is working with government authorities to educate patients about the need to get flu shots.

January 16, 2013

Specialty pharmacy service provider Noble Health Associates, a newly created subsidiary of regional player Kinney Drugs, is looking to open a mail-order facility in DeWitt, N.Y., according to a local news report.

January 16, 2013

Specialty drug spend will surpass traditional drug spend by 2018 for commercial plan sponsors, according to a new study.

January 15, 2013

H. D. Smith announced plans to secure majority ownership in Triplefin, a privately held reimbursement, patient assistance and pharmaceutical brand support services company headquartered in Cincinnati, Ohio.

January 15, 2013

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

January 15, 2013

A drug-security product has won a drug-abuse prevention award.

January 10, 2013

Demand among consumers for online services from drug companies to help manage chronic conditions is strong, according to a new study from healthcare market research firm Manhattan Research.

January 10, 2013

The National Association of Chain Drug Stores has expanded its program lineup for the upcoming 2013 Regional Chain Conference to now include a new session of specialty pharmacy.

January 9, 2013

Ten issues will take center stage as the healthcare industry moves to meet the requirements of the Patient Protection and Affordable Care Act, according to a new report by PricewaterhouseCoopers.

January 9, 2013

Drug Store News has introduced a new app for print subscribers to DSN magazine: DSN+.

January 9, 2013

One of the most serious drug abuse problems in the country doesn't involve heroin, methamphetamine or crack, but abuse of legal prescription drugs, particularly opioid painkillers, a problem that the Food and Drug Administration aims to change with draft guidance released Wednesday.

January 8, 2013

Abbott Labs has spun off its specialty drug division into a new company called AbbVie, which the new company's leaders heralded Wednesday by ringing the first opening bell of 2013 at the New York Stock Exchange.

January 8, 2013

Biotech companies saw a decline in project delays due to regulations over the past year, as more than half have said insurance coverage and reimbursement issues have become more difficult, according to a new report.

January 8, 2013

An organization focused on inflammatory bowel disease has enlisted a star of "NYPD Blue," "Judging Amy" and "Private Practice" to raise awareness of the condition.

January 7, 2013

Biogen Idec is seeking Food and Drug Administration approval for a hemophilia drug that it called the first of its kind.

January 7, 2013

While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.

January 7, 2013

Massachusetts Gov. Deval Patrick has introduced legislation that would give the state government broader power over compounding pharmacies, the governor's office announced.

January 4, 2013

The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.

January 4, 2013

Ahold banner Giant Food of Landover, Md., donated $37,305 to the Capital Breast Care Center.

January 3, 2013

An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said.

January 2, 2013

In 2012, the Food and Drug Administration approved 39 new drugs, 8 alone in December, marking the largest increase in 16 years.

January 2, 2013

The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.